deltatrials
Terminated PHASE2 INTERVENTIONAL 1-arm NCT00001151

Studies With 1,25-Dihydroxycholecalciferol

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions Hypocalcemia Rickets
Interventions 1,25-Dihydroxycholecalciferol
Updated 7 times since 2017 Last updated: Nov 21, 2013 Started: Mar 31, 1976 Primary completion: Oct 31, 2009 Completion: Oct 31, 2009
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Terminated because of lack of drug supply

Other terminated trials from National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

See all terminations from National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Other Hypocalcemia trials with similar outcome

Browse all Hypocalcemia trials

Listed as NCT00001151, this PHASE2 trial focuses on Hypocalcemia and Rickets and remains terminated or withdrawn. Sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), it has been updated 7 times since 1976, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotTerminated~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotTerminated~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 24 months · monthly snapshotTerminated

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Jan 2023 — Jul 2024 [monthly]

    Terminated PHASE2

  4. Dec 2022 — Jan 2023 [monthly]

    Terminated PHASE2

  5. Jan 2021 — Dec 2022 [monthly]

    Terminated PHASE2

▶ Show 2 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE2

  2. Jan 2017 — Jun 2018 [monthly]

    Terminated PHASE2

    First recorded

Mar 1976

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations